In fact, it has been demonstrated that, in chronic fatigue syndrome, serum IgA anti-Pseudomonas LPS increases compared to healthy controls, and their levels positively correlate with the clinical symptoms of these patients [82]. This evidence concerns the gene CD79A and myalgic encephalomeyelitis/chronic fatigue syndrome.